Global /South Korea /Healthcare /Drug Manufacturers - General /007370

Jin Yang Pharmaceutical Co., Ltd.

007370

• KRX: 007370 • Delayed

4,940KRW 1.2%

3.27 USD

As of 18 June 2026, Jin Yang Pharmaceutical Co., Ltd. has a market cap of $41.9M USD, ranking #31804 globally and #1873 in South Korea. It ranks #2878 in the Healthcare sector, and #1002 in the Drug Manufacturers - General industry.

Global Rank

31804

Country Rank

1873

Sector Rank

2878

Industry Rank

1002

Key Stats

Market Cap

$41.9MUSD

63.91B KRW

Enterprise Value

$89.29MUSD

134.77B KRW

Revenue (TTM)

$79.12MUSD

120.69B KRW

EBITDA (TTM)

$3.27MUSD

4.93B KRW

Net Income (TTM)

$14.61MUSD

22.29B KRW

EBITDA Margin

4.1%

Profit Margin

18%

PE Ratio

2.9

PS Ratio

0.5

PB Ratio

0.4

EV/EBITDA

27.3

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Jae-Joon Choi open_in_new

Employees

220

Founded

1971

Website

jinyangpharm.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
1.2%	3.9%	6.1%	-3.5%	-11%	-1.8%	-19%	-14%	-22%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	007370 진양제약(주) ISIN: KR7007370000 Shares Out.: Shares Outstanding: 14.135M¹ Shares Float: 11.686M² TV: TradingView: KRX: 007370 SA: Stock Analysis: KRX: 007370 YF: Yahoo Finance: 007370.KS GF: Google Finance: KRX: 007370 BA: Barron's: 007370 MS: Morningstar: XKRX: 007370	4,940 KRW	TV: TradingView: KRX: 007370 SA: Stock Analysis: KRX: 007370 YF: Yahoo Finance: 007370.KS GF: Google Finance: KRX: 007370 BA: Barron's: 007370 MS: Morningstar: XKRX: 007370

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Jin Yang Pharmaceutical Co., Ltd.

Jin Yang Pharmaceutical Co., Ltd. engages in the pharmaceutical business in South Korea. The company offers crivix tablets, Eszol tablets, atolan tablets, prescription drugs, and over-the-counter drugs. It also offers antilipidemic, antiplatelet, gastrointestinal, and respiratory agents; antithrombotics; NSAIDs; menopause symptoms treatment; and stomatological products. The company also exports its products. Jin Yang Pharmaceutical Co., Ltd. was founded in 1971 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.12B 13.91T KRW 22K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.75B 10.3T KRW 16K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.23B 7.97T KRW 12K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.95B 7.55T KRW 12K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.54B 6.92T KRW 11K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.43B 6.76T KRW 10K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 2M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 1M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 861K%	97.4	United States
Roche Holding AG SIX: RO	$321.45B 256.25B CHF 767K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$287.52B 215.59B GBP 686K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.59B 218.9B CHF 655K%	20.5	Switzerland

chevron_leftBack